Liao Dengyong, Li Dan, Wang Ruoran, Xu Jianguo, Chen Haifeng
Department of Neurosurgery, West China Hospital, Sichuan University, Chengdu, China.
Department of Physiology, School of Basic Medical Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Front Neurol. 2023 Jan 11;13:1094073. doi: 10.3389/fneur.2022.1094073. eCollection 2022.
We report our experience with the use of hemilaminectomy approach for the removal of benign intraspinal tumors.
A retrospective review of 1,067 patients who underwent hemilaminectomy in our hospital between 2013 and 2019 was analyzed. Baseline medical data were collected. One hundred sixteen patients were excluded due to degenerative diseases, spinal bone tumors, and malignant tumors. The remaining 901 patients (916 tumors) were enrolled. The Dennis Pain Scale (DPS) was used to assess improvement in pain before surgery and during long-term follow-up. Neurological status was assessed using the American Spinal Injury Association (ASIA) impairment scale.
The age of the patients was 48.7 ± 15.3 years, the duration of symptoms was 16.5 ± 32.0 months, and the tumor size was 2.6 ± 1.4 cm. Three hundred two tumors were located in the cervical region, 42 in the cervicothoracic region, 234 in the thoracic region, 57 in the thoracolumbar region, and 281 in the lumbar and lumbosacral region. Twenty-three tumors were ventrally located, 677 were dorsal or dorsolateral, 63 were intramedullary, 87 were epidural, and the rest were dumbbell-shaped. The most common pathologies were schwannomas (601, 66.7%) and meningiomas (172, 19.1%). Total excision was achieved at 97.8%. The operative time was 94.3 ± 32.6 min and the blood loss during surgery was 96.9 ± 116.5 ml. The symptom of pain improved in 87.0% of patients during long-term follow-up, neurological function improved in 68.3% and remained unchanged at 30.5%.
The hemilaminectomy approach was a rapid and safe procedure to remove intradural and extradural tumors. This approach has offered several advantages. It could be used for the resection of most extradural or intradural extramedullary lesions, even some intramedullary tumors.
我们报告采用半椎板切除术治疗椎管内良性肿瘤的经验。
对2013年至2019年在我院接受半椎板切除术的1067例患者进行回顾性分析。收集基线医学数据。116例患者因退行性疾病、脊柱骨肿瘤和恶性肿瘤被排除。其余901例患者(916个肿瘤)被纳入研究。采用丹尼斯疼痛量表(DPS)评估术前及长期随访期间疼痛的改善情况。使用美国脊髓损伤协会(ASIA)损伤量表评估神经功能状态。
患者年龄为48.7±15.3岁,症状持续时间为16.5±32.0个月,肿瘤大小为2.6±1.4 cm。302个肿瘤位于颈椎区域,42个位于颈胸区域,234个位于胸椎区域,57个位于胸腰区域,281个位于腰椎和腰骶区域。23个肿瘤位于腹侧,677个位于背侧或背外侧,63个位于髓内,87个位于硬膜外,其余为哑铃形。最常见的病理类型是神经鞘瘤(601个,66.7%)和脑膜瘤(172个,19.1%)。全切率达97.8%。手术时间为94.3±32.6分钟,术中出血量为96.9±116.5毫升。长期随访期间,87.0%的患者疼痛症状改善,神经功能改善的患者占68.3%,保持不变的患者占30.5%。
半椎板切除术是一种快速、安全的切除硬膜内和硬膜外肿瘤的手术方法。该方法具有诸多优势。它可用于切除大多数硬膜外或硬膜内髓外病变,甚至一些髓内肿瘤。